Advent Pharma Ltd. reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was BDT 137.13 million compared to BDT 131.67 million a year ago. Net income was BDT 25.1 million compared to BDT 26.56 million a year ago. Basic earnings per share from continuing operations was BDT 0.27 compared to BDT 0.29 a year ago.
For the six months, sales was BDT 288.8 million compared to BDT 282.98 million a year ago. Net income was BDT 57.36 million compared to BDT 64.28 million a year ago. Basic earnings per share from continuing operations was BDT 0.62 compared to BDT 0.69 a year ago.